Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Smidt

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2015
Contralateral lymph node recurrence in breast cancer: Regional event rather than distant metastatic disease. A systematic review of the literatureM Moossdorff, G Vugts, A J G Maaskant-Braat, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 3, 2015
The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: A systematic review and meta-analysisT J A van Nijnatten, R J Schipper, M B I Lobbes, et al.
European Radiology|September 18, 2012
Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic reviewR Prevos, M L Smidt, V C G Tjan-Heijnen, et al.
Breast (Edinburgh, Scotland)|June 9, 2015
The changing role of axillary treatment in breast cancer: Who will remain at risk for developing arm morbidity in the future?T R Lopez Penha, L M van Roozendaal, M L Smidt, et al.
The British Journal of Surgery|October 14, 2014
Inconsistent selection and definition of local and regional endpoints in breast cancer researchM Moossdorff, L M van Roozendaal, R-J Schipper, et al.
Breast (Edinburgh, Scotland)|October 8, 2013
Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?R J Schipper, L M van Roozendaal, B de Vries, et al.
Breast Cancer Research and Treatment|October 4, 2023
Gene expression profiles in clinically T1-2N0 ER+HER2- breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performedL M van Roozendaal, M L G Vane, E Colier, et al.
Breast Cancer Research and Treatment|March 18, 2020
De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based studyJ M Simons, L B Koppert, E J T Luiten, et al.
Breast Cancer Research and Treatment|March 10, 2021
Conditional local recurrence risk: the effect of event-free years in different subtypes of breast cancerM Moossdorff, Marissa L G Vane, T J A van Nijnatten, et al.
European Journal of Radiology|September 25, 2017
Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefitsI P L Houben, P Van de Voorde, C R L P N Jeukens, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2015
Contralateral lymph node recurrence in breast cancer: Regional event rather than distant metastatic disease. A systematic review of the literatureM Moossdorff, G Vugts, A J G Maaskant-Braat, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 3, 2015
The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: A systematic review and meta-analysisT J A van Nijnatten, R J Schipper, M B I Lobbes, et al.
European Radiology|September 18, 2012
Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic reviewR Prevos, M L Smidt, V C G Tjan-Heijnen, et al.
Breast (Edinburgh, Scotland)|June 9, 2015
The changing role of axillary treatment in breast cancer: Who will remain at risk for developing arm morbidity in the future?T R Lopez Penha, L M van Roozendaal, M L Smidt, et al.
The British Journal of Surgery|October 14, 2014
Inconsistent selection and definition of local and regional endpoints in breast cancer researchM Moossdorff, L M van Roozendaal, R-J Schipper, et al.
Breast (Edinburgh, Scotland)|October 8, 2013
Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?R J Schipper, L M van Roozendaal, B de Vries, et al.
Breast Cancer Research and Treatment|October 4, 2023
Gene expression profiles in clinically T1-2N0 ER+HER2- breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performedL M van Roozendaal, M L G Vane, E Colier, et al.
Breast Cancer Research and Treatment|March 18, 2020
De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based studyJ M Simons, L B Koppert, E J T Luiten, et al.
Breast Cancer Research and Treatment|March 10, 2021
Conditional local recurrence risk: the effect of event-free years in different subtypes of breast cancerM Moossdorff, Marissa L G Vane, T J A van Nijnatten, et al.
European Journal of Radiology|September 25, 2017
Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefitsI P L Houben, P Van de Voorde, C R L P N Jeukens, et al.
Pageof 5